Healthcare Providers and Services
Company Overview of Brigham and Women's Hospital
Brigham and Women's Hospital, an academic medical center, operates inpatient and outpatient facilities, clinics, primary care health centers, and diagnostic and treatment technologies and research laboratories. It provides clinical, translational, bench, and population-based research studies, including nurses health studies, physicians health studies, and the women's health initiatives. The company also offers cardiovascular medicine, neurology, neurosurgery, newborn medicine, obstetrics and gynecology, orthopedic surgery, pathology, psychiatry, radiation oncology, radiology, surgery, women’s health, arthritis and rheumatic disorders, orthopedics, pain management, dermatology, emergency medi...
75 Francis Street
Boston, MA 02115
Founded in 1980
Key Executives for Brigham and Women's Hospital
Chief Operating Officer and Executive Vice President
Senior Vice President of Communication and Public Affairs
Director of Public Affairs
Compensation as of Fiscal Year 2014.
Brigham and Women's Hospital Key Developments
NanoString Technologies, Inc. Collaborates with Brigham and Women's Hospital to Accelerate Translation of Genomic Discoveries into Clinical Diagnostics in Oncology
Oct 6 14
NanoString Technologies, Inc. announced that it has signed a multi-year, multi-investigator research collaboration with Brigham and Women's Hospital to accelerate the translation of genomic biomarker discoveries into clinical cancer diagnostics. Using NanoString's Elements reagents, assays will be developed to detect gene expression, copy number variations, and fusions from a diverse range of tumor samples. NanoString's nCounter(R) Analysis System is an automated and easy-to-use platform that utilizes a novel digital barcoding chemistry to deliver high precision multiplexed assays across a number of important research applications. The research collaboration will enable the researchers at Brigham and Women's Hospital to evaluate and analyze a repository of patient derived tumor tissues for identification of gene signatures and gene expression profiles that typify a specific tumor type. This knowledge is expected to fuel the development of validated diagnostic tests with potential to vastly improve clinical decisions involved in treatment of cancer patients. Under the terms of the agreement, NanoString retains the right to license diagnostic content developed within the scope of the collaboration.
Brigham and Women's Hospital Presents at Citi's 9th Annual Biotech Conference, Sep-03-2014 through Sep-04-2014
Aug 12 14
Brigham and Women's Hospital Presents at Citi's 9th Annual Biotech Conference, Sep-03-2014 through Sep-04-2014. Venue: The Mandarin Oriental Boston, 776 Boylston Street, Boston, MA 02119, United States. Presentation Date & Speakers: Sep-03-2014, Vijay Kuchroo, Ph.D., Professor of Neurology. Sep-04-2014, Howard L. Weiner, M.D., Co-Director of the Center for Neurologic Diseases.
Brigham and Women's Hospital Presents at Deutsche Bank Securities 39th Annual Health Care Conference, May-08-2014 12:00 PM
Apr 26 14
Brigham and Women's Hospital Presents at Deutsche Bank Securities 39th Annual Health Care Conference, May-08-2014 12:00 PM. Venue: The InterContinental Hotel, 510 Atlantic Ave, Boston, MA 02210, United States. Speakers: Christopher Thompson, Director of Therapeutic Endoscopy.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|